Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BIOAFFINITY TECHNOLOGIES, INC.

(BIAF)
Delayed Nasdaq  -  01:46 2022-12-07 pm EST
2.900 USD   -3.97%
12/01Bioaffinity Technologies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/01bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
BU
11/14BIOAFFINITY TECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Sagging Just Ahead of Wednesday Close

09/14/2022 | 03:56pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIOAFFINITY TECHNOLOGIES, INC. -3.97% 2.9 Delayed Quote.0.00%
CROSS COUNTRY HEALTHCARE, INC. -2.36% 32.73 Delayed Quote.25.79%
EXSCIENTIA PLC 0.40% 5 Delayed Quote.-74.80%
GENFIT 0.73% 3.33 Real-time Quote.-23.40%
NASDAQ COMPOSITE -0.48% 10963.02 Real-time Quote.-29.59%
All news about BIOAFFINITY TECHNOLOGIES, INC.
12/01Bioaffinity Technologies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
12/01bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB..
BU
11/14BIOAFFINITY TECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condi..
AQ
11/14BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/14bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Busi..
BU
11/14Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Reports Q3 Revenue $1,150
MT
11/11BioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company..
AQ
11/10Bioaffinity Technologies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
11/10bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company..
BU
11/10Bioaffinity Technologies Announces Joining of Sheila Habib and David Hill to Scientific..
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -6,33 M - -
Net Debt 2021 10,0 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 25,3 M 25,3 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 11
Free-Float 74,6%
Chart BIOAFFINITY TECHNOLOGIES, INC.
Duration : Period :
bioAffinity Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOAFFINITY TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBullish
Income Statement Evolution
Managers and Directors
Maria Zannes President, Chief Executive Officer & Director
J. Michael Edwards Chief Financial Officer
Steven Girgenti Executive Chairman
Vivienne Rebel Chief Science & Medical Officer, EVP
William Bauta SVP-Research & Development, Therapeutics
Sector and Competitors